Gene expression studies implicated CEP55 in progression from in situ to invasive breast cancer (Ma et al, 2003), and overexpression in primary breast tumors is a marker of chromosomal instability and poor prognosis (Carter et al, 2006; Fournier et al, 2006). Here, CEP55 is linked to breast neoplasm.